Pituitary–gonadal hormones associated with respiratory failure in men and women hospitalized with COVID-19: an observational cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Pituitary–gonadal hormones associated with respiratory failure in men and women hospitalized with COVID-19 : an observational cohort study. / Clausen, Clara Lundetoft; Johannsen, Trine Holm; Skakkebæk, Niels Erik; Frederiksen, Hanne; Ryrsø, Camilla Koch; Dungu, Arnold Matovu; Hegelund, Maria Hein; Faurholt-Jepsen, Daniel; Krogh-Madsen, Rikke; Lindegaard, Birgitte; Linneberg, Allan; Kårhus, Line Lund; Juul, Anders; Benfield, Thomas.

In: Endocrine Connections, Vol. 12, No. 1, e220444, 2023.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Clausen, CL, Johannsen, TH, Skakkebæk, NE, Frederiksen, H, Ryrsø, CK, Dungu, AM, Hegelund, MH, Faurholt-Jepsen, D, Krogh-Madsen, R, Lindegaard, B, Linneberg, A, Kårhus, LL, Juul, A & Benfield, T 2023, 'Pituitary–gonadal hormones associated with respiratory failure in men and women hospitalized with COVID-19: an observational cohort study', Endocrine Connections, vol. 12, no. 1, e220444. https://doi.org/10.1530/EC-22-0444

APA

Clausen, C. L., Johannsen, T. H., Skakkebæk, N. E., Frederiksen, H., Ryrsø, C. K., Dungu, A. M., Hegelund, M. H., Faurholt-Jepsen, D., Krogh-Madsen, R., Lindegaard, B., Linneberg, A., Kårhus, L. L., Juul, A., & Benfield, T. (2023). Pituitary–gonadal hormones associated with respiratory failure in men and women hospitalized with COVID-19: an observational cohort study. Endocrine Connections, 12(1), [e220444]. https://doi.org/10.1530/EC-22-0444

Vancouver

Clausen CL, Johannsen TH, Skakkebæk NE, Frederiksen H, Ryrsø CK, Dungu AM et al. Pituitary–gonadal hormones associated with respiratory failure in men and women hospitalized with COVID-19: an observational cohort study. Endocrine Connections. 2023;12(1). e220444. https://doi.org/10.1530/EC-22-0444

Author

Clausen, Clara Lundetoft ; Johannsen, Trine Holm ; Skakkebæk, Niels Erik ; Frederiksen, Hanne ; Ryrsø, Camilla Koch ; Dungu, Arnold Matovu ; Hegelund, Maria Hein ; Faurholt-Jepsen, Daniel ; Krogh-Madsen, Rikke ; Lindegaard, Birgitte ; Linneberg, Allan ; Kårhus, Line Lund ; Juul, Anders ; Benfield, Thomas. / Pituitary–gonadal hormones associated with respiratory failure in men and women hospitalized with COVID-19 : an observational cohort study. In: Endocrine Connections. 2023 ; Vol. 12, No. 1.

Bibtex

@article{611d46f14bec41528ac579d603e12f0a,
title = "Pituitary–gonadal hormones associated with respiratory failure in men and women hospitalized with COVID-19: an observational cohort study",
abstract = "Aim: To explore pituitary–gonadal hormone concentrations and assess their association with inflammation, severe respiratory failure, and mortality in hospitalized men and women with COVID-19, and compare these to hormone concentrations in hospitalized patients with bacterial community-acquired pneumonia (CAP) and influenza virus CAP and to concentrations in a reference group of healthy individuals. Methods: Serum concentrations of testosterone, estrone sulfate, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and interleukin-6 (IL-6) were measured within 4 days of admission. Associations were assessed by logistic regression analysis in patients with COVID-19, and results were reported as odds ratio with 95% CI per two-fold reduction after adjustment for age, comorbidities, days to sample collection, and IL-6 concentrations. Results: In total, 278 patients with COVID-19, 21 with influenza virus CAP, and 76 with bacterial CAP were included. Testosterone concentrations were suppressed in men hospitalized with COVID-19, bacterial and influenza virus CAP, and moderately suppressed in women. Reductions in testosterone (OR: 3.43 (1.14–10.30), P = 0.028) and LH (OR: 2.51 (1.28–4.92), P = 0.008) were associated with higher odds of mehanical ventilation (MV) in men with COVID-19. In women with COVID-19, reductions in LH (OR: 3.34 (1.02–10-90), P = 0.046) and FSH (OR: 2.52 (1.01–6.27), P = 0.047) were associated with higher odds of MV. Conclusion: Low testosterone and LH concentrations were predictive of severe respiratory failure in men with COVID-19, whereas low concentrations of LH and FSH were predictive of severe respiratory failure in women with COVID-19.",
keywords = "COVID-19, estrone-sulfate, FSH, hypogonadism, LH, morbidity, mortality, testosterone",
author = "Clausen, {Clara Lundetoft} and Johannsen, {Trine Holm} and Skakkeb{\ae}k, {Niels Erik} and Hanne Frederiksen and Ryrs{\o}, {Camilla Koch} and Dungu, {Arnold Matovu} and Hegelund, {Maria Hein} and Daniel Faurholt-Jepsen and Rikke Krogh-Madsen and Birgitte Lindegaard and Allan Linneberg and K{\aa}rhus, {Line Lund} and Anders Juul and Thomas Benfield",
note = "Publisher Copyright: {\textcopyright} 2022 The authors Published by Bioscientifica Ltd.",
year = "2023",
doi = "10.1530/EC-22-0444",
language = "English",
volume = "12",
journal = "Endocrine Connections",
issn = "2049-3614",
publisher = "BioScientifica Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Pituitary–gonadal hormones associated with respiratory failure in men and women hospitalized with COVID-19

T2 - an observational cohort study

AU - Clausen, Clara Lundetoft

AU - Johannsen, Trine Holm

AU - Skakkebæk, Niels Erik

AU - Frederiksen, Hanne

AU - Ryrsø, Camilla Koch

AU - Dungu, Arnold Matovu

AU - Hegelund, Maria Hein

AU - Faurholt-Jepsen, Daniel

AU - Krogh-Madsen, Rikke

AU - Lindegaard, Birgitte

AU - Linneberg, Allan

AU - Kårhus, Line Lund

AU - Juul, Anders

AU - Benfield, Thomas

N1 - Publisher Copyright: © 2022 The authors Published by Bioscientifica Ltd.

PY - 2023

Y1 - 2023

N2 - Aim: To explore pituitary–gonadal hormone concentrations and assess their association with inflammation, severe respiratory failure, and mortality in hospitalized men and women with COVID-19, and compare these to hormone concentrations in hospitalized patients with bacterial community-acquired pneumonia (CAP) and influenza virus CAP and to concentrations in a reference group of healthy individuals. Methods: Serum concentrations of testosterone, estrone sulfate, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and interleukin-6 (IL-6) were measured within 4 days of admission. Associations were assessed by logistic regression analysis in patients with COVID-19, and results were reported as odds ratio with 95% CI per two-fold reduction after adjustment for age, comorbidities, days to sample collection, and IL-6 concentrations. Results: In total, 278 patients with COVID-19, 21 with influenza virus CAP, and 76 with bacterial CAP were included. Testosterone concentrations were suppressed in men hospitalized with COVID-19, bacterial and influenza virus CAP, and moderately suppressed in women. Reductions in testosterone (OR: 3.43 (1.14–10.30), P = 0.028) and LH (OR: 2.51 (1.28–4.92), P = 0.008) were associated with higher odds of mehanical ventilation (MV) in men with COVID-19. In women with COVID-19, reductions in LH (OR: 3.34 (1.02–10-90), P = 0.046) and FSH (OR: 2.52 (1.01–6.27), P = 0.047) were associated with higher odds of MV. Conclusion: Low testosterone and LH concentrations were predictive of severe respiratory failure in men with COVID-19, whereas low concentrations of LH and FSH were predictive of severe respiratory failure in women with COVID-19.

AB - Aim: To explore pituitary–gonadal hormone concentrations and assess their association with inflammation, severe respiratory failure, and mortality in hospitalized men and women with COVID-19, and compare these to hormone concentrations in hospitalized patients with bacterial community-acquired pneumonia (CAP) and influenza virus CAP and to concentrations in a reference group of healthy individuals. Methods: Serum concentrations of testosterone, estrone sulfate, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and interleukin-6 (IL-6) were measured within 4 days of admission. Associations were assessed by logistic regression analysis in patients with COVID-19, and results were reported as odds ratio with 95% CI per two-fold reduction after adjustment for age, comorbidities, days to sample collection, and IL-6 concentrations. Results: In total, 278 patients with COVID-19, 21 with influenza virus CAP, and 76 with bacterial CAP were included. Testosterone concentrations were suppressed in men hospitalized with COVID-19, bacterial and influenza virus CAP, and moderately suppressed in women. Reductions in testosterone (OR: 3.43 (1.14–10.30), P = 0.028) and LH (OR: 2.51 (1.28–4.92), P = 0.008) were associated with higher odds of mehanical ventilation (MV) in men with COVID-19. In women with COVID-19, reductions in LH (OR: 3.34 (1.02–10-90), P = 0.046) and FSH (OR: 2.52 (1.01–6.27), P = 0.047) were associated with higher odds of MV. Conclusion: Low testosterone and LH concentrations were predictive of severe respiratory failure in men with COVID-19, whereas low concentrations of LH and FSH were predictive of severe respiratory failure in women with COVID-19.

KW - COVID-19

KW - estrone-sulfate

KW - FSH

KW - hypogonadism

KW - LH

KW - morbidity

KW - mortality

KW - testosterone

U2 - 10.1530/EC-22-0444

DO - 10.1530/EC-22-0444

M3 - Journal article

C2 - 36472925

AN - SCOPUS:85146297732

VL - 12

JO - Endocrine Connections

JF - Endocrine Connections

SN - 2049-3614

IS - 1

M1 - e220444

ER -

ID: 334264812